NRXS
NEURAXIS (NRXS)
NYSE
$7.08+$0.07 (+0.96%)
Price as of Jun 03, 2026 7:22 PM EDT
  • $91.8M
    Market Cap
  • 153.07%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
3.6M
+32.89%
2.7M
+9.18%
2.5M
N/A
Cost of Revenue
562,916
+55.50%
362,002
+19.34%
303,345
N/A
Gross Profit
3.0M
+29.37%
2.3M
+7.75%
2.2M
N/A
Sales and Marketing Expense
2.3M
+602.16%
324,708
+0.35%
323,569
N/A
Research and Development Expense
-493,611
+139.49%
-206,107
+21.73%
-169,315
N/A
Depreciation and Amortization Expense
59,501
+57.28%
37,831
-7.11%
40,725
N/A
Total Operating Expenses
562,916
+55.50%
362,002
+19.34%
303,345
N/A
Operating Profit
-7.8M
+9.40%
-7.2M
+7.39%
-6.7M
N/A
Interest Income
141,196
+319.98%
33,620
+122.16%
15,133
N/A
Interest Expense
-73,969
-57.57%
-174,328
-63.41%
-476,416
N/A
Interest Income and Expense and Net
67,227
+147.78%
-140,708
-69.50%
-461,283
N/A
Total Nonoperating Income and Expense
29,353
+102.71%
-1.1M
-86.38%
-8.0M
N/A
Income before Taxes
-8.6M
+1.92%
-8.5M
+26.83%
-6.7M
N/A
Income Taxes
-2.0M
+25.53%
-1.6M
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-8.6M
+1.92%
-8.5M
-42.21%
-14.6M
N/A
Net Income from Continuing Operations Applicable to Common
-8.6M
+1.92%
-8.5M
-42.21%
-14.6M
N/A
Basic EPS and Net Income
-0.95
-22.13%
-1.22
-72.89%
-4.50
N/A
Diluted EPS and Net Income
-0.95
-22.13%
-1.22
-72.89%
-4.50
N/A
Basic Weighted Average Shares
9.1M
+31.28%
6.9M
+112.74%
3.3M
N/A
Diluted Weighted Average Shares
9.1M
+31.28%
6.9M
+112.74%
3.3M
N/A
Balance Sheet
Cash and Cash Equivalents
5.0M
+34.30%
3.7M
+4,605.79%
78,560
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
5.0M
+34.30%
3.7M
+4,605.79%
78,560
N/A
Total Current Assets
5.7M
+34.39%
4.3M
+1,658.45%
242,610
N/A
Accumulated Depreciation
306,901
-18.03%
374,420
+7.57%
348,074
N/A
Property and Plant and Equipment and Net
75,564
-16.02%
89,982
+1.61%
88,552
N/A
Total Long-Term Assets
58,939
-34.50%
89,982
+1.61%
88,552
N/A
Total Assets
6.4M
+34.61%
4.8M
+833.78%
509,498
N/A
Income Taxes Payable
692,683
+395.79%
139,713
+14,408.10%
963
N/A
Total Short-Term Debt
148,293
-3.80%
154,152
+4.11%
148,062
N/A
Total Current Liabilities
2.8M
+14.74%
2.4M
+29.04%
1.9M
N/A
Total Long-Term Debt
3.2M
+5.67%
3.0M
-4.70%
3.1M
N/A
Total Long-Term Liabilities
212,565
-17.13%
256,499
+847.50%
27,071
N/A
Total Liabilities
3.0M
+11.70%
2.7M
+40.63%
1.9M
N/A
Retained Earnings
-64.6M
+13.73%
-56.8M
+16.97%
-48.6M
N/A
Total Stockholders Equity
3.4M
N/A
N/A
N/A
-1.4M
N/A
Total Shares Outstanding
10.7M
+52.40%
7.0M
+7.39%
6.5M
N/A
Cash Flow
Cash from Operating Activities
-6.4M
+5.49%
-6.1M
-8.90%
-6.7M
N/A
Capital Expenditures
31,150
+12.15%
27,776
-9.76%
30,781
N/A
Cash from Investing Activities
-131,150
+372.17%
-27,776
-61.30%
-71,781
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
7.8M
-19.62%
9.7M
+47.85%
6.6M
N/A
Financials Ratio
Gross Margin
84.23%
-2.65%
86.52%
N/A
N/A
N/A
Operating Margin
-219.37%
-17.67%
-266.46%
N/A
N/A
N/A
Return on Assets
-154.37%
-51.90%
-320.97%
N/A
N/A
N/A
Return on Equity
N/A
N/A
N/A
N/A
N/A
N/A
Revenue Growth
32.89%
+258.19%
9.18%
N/A
N/A
N/A
Current Ratio
2.05
+17.12%
1.75
N/A
N/A
N/A
Cash Ratio
1.78
+17.05%
1.52
N/A
N/A
N/A
Debt-to-Equity Ratio
0.98
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.52
-21.84%
0.66
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow